Thank you, Dr. Anirban Maitra @Aiims1742 for your excellent presentation and visit to New Haven! Watch Dr. Maitra's full talk, "Mediators of Restraint in Early Pancreatic Neoplasia," on our YouTube channel: piped.video/j_VYvB0R3_Y?si=ng6H…. @SmilowCancer @Perlmutter_CC @PamelaKunzMD

While #cancerscreening saves lives, if you aren't at the recommended age for screening, Dr. Michaela Dinan says: "If you are experiencing symptoms, regardless of your age, you should speak with your doctor about that." nbcconnecticut.com/news/loca… @YaleCancer @YaleSPH

"Cancer research is a team effort,” says Dr. Katerina Politi, deputy director, @YaleCancer. On #WorldCancerResearchDay, we celebrate the people who make progress in #cancerresearch possible. From discovery in the lab to clinical trials and patient care, everyone plays an essential role. @SmilowCancer @yalepathology

.@SmilowCancer’s Cellular Therapy Program is proud to announce that it ranks 3rd in the nation in the number of patients treated with #Breyanzi, an FDA-approved CAR T-cell therapy for #bloodcancers. This recognition, tracked by @CIBMTR, reflects the experience, expertise, and dedication of the Smilow Cellular Therapy team in delivering advanced #cellulartherapy to patients. We’re proud of this achievement and remain committed to providing exceptional care to patients facing these complex diagnoses. @YaleCancer @YaleHematology #CART

Today at 12pm, we are pleased to welcome Dr. Anirban Maitra @Aiims1742 for our #GrandRounds and Koenigsberg Lecture! Dr. Maitra will present "Mediators of Restraint in Early Pancreatic Neoplasia." Join us in Smilow Auditorium or online via Zoom: bit.ly/4gWZv7G. @SmilowCancer @Perlmutter_CC

.@cececalhounMD joined the #HemeTalks #Podcast to discuss one of the most vulnerable moments in #sicklecell care: the transition from pediatric to adult management. Dr. Calhoun shared a case discussion & how to build trust with adolescent and young adult patients. open.spotify.com/episode/53B… @SmilowCancer @YaleHematology @ASH_hematology

📺 In this episode of The Moonlight Shift, @JyotiMalhotraMD discusses first-in-human clinical trials, lung cancer precision medicine in 2026, the disparities tension in drug development, and her move to @YaleCancer. #lcsm #oncology Watch now ➡️: onclive.com/view/first-in-hu…

We’re grateful for the @Yale College Class of 1961 #CancerEndowment, which has grown to more than $3.5 million, awarding over $900,000 in research grants to young scientists at @YaleCancer. medicine.yale.edu/news-artic… @SmilowCancer

This morning’s Smilow Salute was an emotional and exciting stop on @CTFRide 💙 A huge thank you to our amazing riders, volunteers, and donors for your enthusiasm and support of patient care and research at @SmilowCancer and Yale Cancer Center. #CTFRide @YNHH

Congratulations to our riders @ncasasanta @DrEricWiner #IanKrop #DanOneil #AveryMarzullaDulfur @YaleCancer

Ready to cheer, celebrate, and show support! Our Smilow Salute cheer squad is out with signs and plenty of excitement as they get ready to welcome and cheer on the #CTFRide riders. 🚴‍♀️🚴‍♂️ @YaleCancer @CTFRide @YNHH

#Osimertinib appears to ⬇️ the elevated brain metastasis risk historically associated with two common subtypes of EGFR mutations, supporting osimertinib's role as a preferred first-line treatment for EGFR-mutant #NSCLC. medicine.yale.edu/cancer/pub… @SmilowCancer @HenryParkMD @VictorLeeYSM @OncoAlert

Inspiring night @TIME 100 Health Leadership Forum. @oliviamunn on breast health. @melindagates on ♀️’s healthy aging. @mariashriver on ♀️’s brain health. @realmikefox asked by TIME’s @AliceParkNY what he wants to be remembered for: work & advocacy toward tackling Parkinson’s.

Congratulations @DrJeremyJacox, recipient of a Seed Grant from the @HirshbergFound. The grant program provides early funding to support basic scientists and clinicians to test innovative ideas for improving diagnosis and developing new treatment modalities for #pancreaticcancer. pancreatic.org/research/seed… @SmilowCancer

Elaine Yang @YaleMed is presenting research during a poster session today at #WCLC in Seoul: "CT-Detected Residual Thymic Tissue Predicts Pathologic Complete Response to Neoadjuvant Therapy in Locally Advanced #NSCLC." cattendee.abstractsonline.co… @SmilowCancer @IASLC

.@VictorLeeYSM will be presenting a mini-oral session today at #WCLC in Seoul: "ATRX Mutations Are Enriched in Female #NSCLC and Associated With Higher Tumor Mutational Burden." cattendee.abstractsonline.co… @SmilowCancer @IASLC @YaleRadOnc

Today is #ApheresisAwarenessDay! Our Apheresis/Photopheresis team provides specialized care for patients living with severe sickle cell disease and beyond, building trusting relationships with patients and families and making a challenging experience feel a little easier. Thank you to our incredible team for all that you do! #AAD2026 #ApheresisDay2026 @YaleHematology @SmilowCancer @Yale_LabMed

Today at 12pm marks the return of our #GrandRounds! Drs. @MaxStahlMD and Jan Bewersdorf present on "New Directions in #AML and #Myelofibrosis." Join us in Smilow Auditorium or online via Zoom. bit.ly/4A7szkr @SmilowCancer @YaleHematology

.@PatrickOhMD will be presenting his research during a poster session today at #WCLC in Seoul: "Poor Survival and Increased Nodal Metastasis in SMARCA4-Mutant Lung Adenocarcinoma in a Multi-Cohort Analysis." cattendee.abstractsonline.co… @SmilowCancer @IASLC @YaleRadOnc

In new #pancreascancer research, @MuzumdarLab et al. find that the pre-existing molecular state of a #PDAC cell exerts greater influence over how a #KRAS mutation behaves than the identity of the mutation itself. medicine.yale.edu/cancer/pub… @SmilowCancer @MolecularOmics @YanixaQuinones @Yanshen73854711